Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Unknown 1Completed 1

Sponsor Class

OTHER 54NIH 5NETWORK 2INDUSTRY 2OTHER_GOV 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 1

Conditions

Lymphoma 50Breast Neoplasms 39Leukemia 33Precursor Cell Lymphoblastic Leukemia-Lymphoma 25Multiple Myeloma 19Neuroblastoma 18Burkitt Lymphoma 17Lymphoma, Large B-Cell, Diffuse 15Lymphoma, Follicular 12Sarcoma 11Leukemia, Lymphocytic, Chronic, B-Cell 11Leukemia, Biphenotypic, Acute 10Hodgkin Disease 10Central Nervous System Neoplasms 9Rhabdomyosarcoma 8Medulloblastoma 8Brain Neoplasms 7Wilms Tumor 6Myelodysplastic Syndromes 6Leukemia, Myeloid, Acute 6Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Lymphoma, Mantle-Cell 5Lymphoma, Large-Cell, Anaplastic 5Inflammatory Breast Neoplasms 5Waldenstrom Macroglobulinemia 4Ovarian Neoplasms 4Neuroectodermal Tumors, Primitive, Peripheral 4Malignant mesenchymal tumor 4Ganglioneuroblastoma 4Dendritic Cell Sarcoma, Interdigitating 4

Interventions

Cyclophosphamide 2trihexyltetradecylphosphonium chloride 1merphos 1Whole-Body Irradiation 1Thiotepa 1Tacrolimus 1Sirolimus 1Methotrexate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Graft vs Host Disease × Cyclophosphamide × Clear all
NCT05158608 2022-01-11

CY25

National Research Center for Hematology, Russia

Phase 3 Unknown
100 enrolled
Other hematologic neoplasm

Graft vs Host Disease, Hematologic Neoplasms

NCT00382109 2019-08-07

Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission

Children's Oncology Group

Phase 3 Completed
146 enrolled 14 charts
LymphoidOther hematologic neoplasm

Graft vs Host Disease, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡